# Denileukin Diftitox Followed by Vaccine Therapy in Treating Patients With Metastatic Cancer

> **NCT00128622** · PHASE1 · COMPLETED · sponsor: **H. Kim Lyerly** · enrollment: 24 (actual)

## Conditions studied

- Breast Cancer
- Colorectal Cancer
- Lung Cancer
- Pancreatic Cancer
- Unspecified Adult Solid Tumor, Protocol Specific

## Interventions

- **BIOLOGICAL:** denileukin diftitox
- **BIOLOGICAL:** recombinant fowlpox-CEA(6D)/TRICOM vaccine
- **BIOLOGICAL:** therapeutic autologous dendritic cells

## Key facts

- **NCT ID:** NCT00128622
- **Lead sponsor:** H. Kim Lyerly
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-09
- **Primary completion:** 2007-03
- **Final completion:** 2009-05
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2012-11-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00128622

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00128622, "Denileukin Diftitox Followed by Vaccine Therapy in Treating Patients With Metastatic Cancer". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00128622. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*